Results 271 to 280 of about 2,211,450 (296)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

Nature Reviews Molecular Cell Biology, 2012
W Lee Kraus
exaly  

Poly(methylphenylphosphazene)-graft-poly(dimethylsiloxane)

Macromolecules, 1989
Patty Wisian-Neilson, M. Safiqul Islam
openaire   +1 more source

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

Rise of Conjugated Poly-ynes and Poly(Metalla-ynes): From Design Through Synthesis to Structure–Property Relationships and Applications

Chemical Reviews, 2018
Ashanul Haque, Rayya A Al-Balushi, Muhammad S Khan   +2 more
exaly  

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Lancet, The, 2010
Michael Friedlander, Clare L Scott, Jeffrey N Weitzel   +2 more
exaly  

Poly(ADP-ribose): novel functions for an old molecule

Nature Reviews Molecular Cell Biology, 2006
Valérie Schreiber, Françoise Dantzer
exaly  

Chapter 4. Polis, Polis

2017
openaire   +1 more source

Structures for the polynucleotide complexes Poly(dA)·Poly(dT) and Poly (dT)·Poly(dA)·Poly(dT)

Journal of Molecular Biology, 1975
openaire   +1 more source

Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers

Cell, 2016
Yi Lin, Eiichiro Mori, Masato Kato
exaly